好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2007 Annual Meeting | Small Fiber Neuropathies: Somatic, Autonomic, or a Mixture of Both

Friday 05/04/07
06:45 AM - 08:30 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Breakfast Seminar
Kamal R. Chemali, MD
Participants should become familiar with the concept of small-fiber and large-fiber neuropathy and with the differential diagnosis and workup of the small fiber neuropathies, including autonomic testing and skin biopsy.
No CME available
Practice-based Learning and Improvement
Advanced
Practitioner, Fellow, Resident, Nurse
Event Timeline
06:30 AM - 08:30 AM Breakfast
06:45 AM - 08:30 AM Small Fiber Neuropathies: Somatic, Autonomic, or a Mixture of Both
Thomas C. Chelimsky, MD, Kamal R. Chemali, MD
Faculty Disclosures
Thomas C. Chelimsky, MD Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Proctor & Gamble. Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Various Legal Firms. Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various Legal Firms. Dr. Chelimsky has received stock or an ownership interest from PainSTakers, LLC. The institution of Dr. Chelimsky has received research support from NIDDK. The institution of Dr. Chelimsky has received research support from Advancing a Healthier Wisconsin.
Kamal R. Chemali, MD Dr. Chemali has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Chemali has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. The institution of Dr. Chemali has received research support from Sjögren's Foundation. The institution of Dr. Chemali has received research support from NIH.